Market Update - November 10 2023
- Bitcoin rises above 37k as ETF momentum continues: Bitcoin rose throughout the week before settling around the 37k range by Friday. The price of BTC was largely in consolidation mode early in the week, which shifted to an upward trajectory after reports surfaced that an eight-day window had opened for the SEC to approve spot bitcoin ETF applications. BTC gained about 7% over the last seven days and is now up more than 25% over the past month.
- Ether launches past $2,000 and BlackRock begins spot ether ETF process: After lagging behind BTC and surging altcoins, ether (ETH) saw renewed strength this week rallying above $2,000. Further bolstering ETH, BlackRock registered an iShares Ethereum Trust in Delaware, which is an early step in the application process for a spot ether ETF.
- Solana continues to rise gaining ~30%, and Ripple signs deals with Georgia and Dubai: Solana (SOL) built on recent gains this week, rallying another ~30% and topping $50 a token by Friday. SOL is now up over 100% over the past three months. XRP also had a positive week benefiting from recently announced Ripple partnerships with Georgia and Dubai. XRP is up ~30% over the past month, and has gained over 50% in the past six months.
- Crypto fund inflows surge over past six weeks: CoinShares data showed $767 million of inflows to crypto funds over the past six weeks, recording the most cash injected since 2021’s bull run. The $767 million in inflows surpassed 2022’s total inflows of $736 million.
- Bankruptcy judge approves Celsius reorganization plan: Defunct crypto lender Celsius had its reorganization plan approved by a Bankruptcy Judge on Thursday. The plan would establish a new entity, NewCo, backed by seed funding of $450 million. The new entity aims to be publicly listed and would be focused on Bitcoin mining and staking. The plan would also require sign off from the SEC. Repayments to creditors could start as soon as early 2024.
🧙Topic of the Week: Origins of Bitcoin
🫱 Read more here
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.